PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.87M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.34%
Positive revenue growth while FLNC is negative. John Neff might see a notable competitive edge here.
9.70%
Gross profit growth under 50% of FLNC's 29.39%. Michael Burry would be concerned about a severe competitive disadvantage.
21.49%
EBIT growth below 50% of FLNC's 129.29%. Michael Burry would suspect deeper competitive or cost structure issues.
21.49%
Operating income growth under 50% of FLNC's 162.49%. Michael Burry would be concerned about deeper cost or sales issues.
24.07%
Net income growth under 50% of FLNC's 108.56%. Michael Burry would suspect the firm is falling well behind a key competitor.
23.00%
EPS growth under 50% of FLNC's 108.44%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
23.00%
Diluted EPS growth under 50% of FLNC's 105.95%. Michael Burry would worry about an eroding competitive position or excessive dilution.
1.07%
Share count expansion well above FLNC's 0.84%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.07%
Diluted share reduction more than 1.5x FLNC's 45.23%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
54.00%
Positive OCF growth while FLNC is negative. John Neff would see this as a clear operational advantage vs. the competitor.
80.96%
Positive FCF growth while FLNC is negative. John Neff would see a strong competitive edge in net cash generation.
-4.16%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-4.16%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-4.16%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
113.23%
10Y OCF/share CAGR 1.25-1.5x FLNC's 84.98%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
113.23%
5Y OCF/share CAGR 1.25-1.5x FLNC's 84.98%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
113.23%
3Y OCF/share CAGR 1.25-1.5x FLNC's 84.98%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
35.56%
Below 50% of FLNC's 100.78%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
35.56%
Below 50% of FLNC's 100.78%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
35.56%
Below 50% of FLNC's 100.78%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
169.40%
10Y equity/share CAGR in line with FLNC's 184.61%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
169.40%
5Y equity/share CAGR is in line with FLNC's 184.61%. Walter Schloss would see parallel mid-term profitability and retention policies.
169.40%
3Y equity/share CAGR similar to FLNC's 184.61%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.19%
Firm’s AR is declining while FLNC shows 2.49%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
24.51%
Inventory growth well above FLNC's 11.94%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.66%
Asset growth well under 50% of FLNC's 10.47%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
0.48%
1.25-1.5x FLNC's 0.37%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-1.91%
We’re deleveraging while FLNC stands at 4.94%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-4.92%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-0.63%
We cut SG&A while FLNC invests at 0.03%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.